Nephrology and Urology Devices Market Size Set for Exponential Growth, Predicted to Surpass USD 47.8 billion by 2032 | CAGR of 4.3%

Allied Market Research published a report, titled, “Nephrology and Urology Devices Market by Product (Instruments and Consumables & Accessories), by Application, (Kidney Diseases, Urological Cancer & BPH, and Others), and by End User, (Hospitals, Dialysis Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global nephrology and urology devices industry generated USD 31.3 billion in 2022, and is anticipated to generate USD 47.8 billion by 2032, witnessing a CAGR of 4.3% from 2023 to 2032.

The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐔𝐫𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Increase in prevalence of kidney and urological disorders such as chronic kidney disease, urinary tract infections, kidney stones, & urologic cancers; surge in technological advancements; and rise in demand for minimally invasive medical procedures drive the growth of the global nephrology and urology devices market. However, the high cost of urology devices restricts market growth. Contrarily, growth prospects in emerging markets present new opportunities in the coming years.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/420  

𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐃𝐨𝐰𝐧𝐭𝐮𝐫𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐑𝐞𝐜𝐞𝐬𝐬𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐨𝐧 𝐭𝐡𝐞 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐔𝐫𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

• During recession, individuals and governments might tighten their budgets, leading to reduced healthcare spending. This could affect patients’ ability to access & afford nephrology and urology devices, potentially leading to decreased demand for diagnostics. In addition, economic downturns lead to reduced funding for medical research and development. This could slow down the advancement of technologies and tools for nephrology and urology devices, potentially limiting the availability of more effective and less invasive diagnostic methods.
• However, rise in the prevalence of urological and nephrological diseases, increase in technological advancements, and growth in awareness about early diagnosis & treatment could boost the need for these devices, leading to a positive impact from the global recession.

𝐓𝐨𝐩 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐔𝐫𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:-

• B. Braun SE
• Baxter International Inc.
• Becton, Dickson and Company
• Boston Scientific Corporation
• Coloplast Ltd
• Karl Storz GmbH & Co. KG
• Medtronic plc
• Olympus Corporation
• Stryker Corporation
• Teleflex Incorporated

The report provides a detailed analysis of these key players in the global nephrology and urology devices market. These players have adopted strategies such as product launch, product approval, acquisition, agreement, and partnership to increase their market share and maintain dominant position in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐔𝐫𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:-

Based on product, the consumables and accessories segment held the largest market share in 2022, accounting for more than three-fifths of the global nephrology and urology devices market revenue and is estimated to maintain its leadership status throughout the forecast period. This segment is projected to manifest the highest CAGR of 4.5% from 2023 to 2032. This is attributed to rise in prevalence of chronic kidney diseases and growth in aging population, which led to surge in demand for urological devices such as consumables.

Depending on application, the kidney diseases segment held the largest market share in 2022, accounting for more than half of the global nephrology and urology devices market and is estimated to maintain its leadership status throughout the forecast period. Increase in the number of people suffering from chronic kidney diseases has led to increase in the demand for urology and nephrology devices which propels the segment growth.

However, the urological cancer & BPH segment is projected to manifest the highest CAGR of 5.4% from 2023 to 2032. This is attributed to increase in awareness of urological cancers, advances in medical technology, and rise in aging population, bring more susceptible to urological conditions such as cancer and BPH.

As per end user, the hospitals segment accounted for the largest share in 2022, contributing to nearly more than two-fifths of the global nephrology and urology devices market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to rise in technological advancements and innovations in nephrology and urology devices making it increasingly feasible to perform procedures in hospital settings.

However, the dialysis centers segment is projected to manifest the highest CAGR of 4.8% from 2023 to 2032. This is attributed to the dialysis centers offering specialized care & medical expertise in managing kidney-related conditions, as a result of which, patients prefer these centers for the convenience of receiving treatment from trained professionals in a clinical setting.

According to region, North America held the largest market share in terms of revenue in 2022, accounting for nearly two-fifths of the global nephrology and urology devices market revenue and is likely to dominate the market during the forecast period. This is attributed to the well-established healthcare system, rise in prevalence of urological diseases, technological advancement in devices, and rise in number of product approvals.

However, Asia-Pacific is expected to witness the highest CAGR of 4.9% from 2023 to 2032. Rise in awareness about early diagnosis & treatment, increase in prevalence of urological & kidney diseases, and development of healthcre industry are expected to drive the growth of the nephrology and urology devices market.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/420   

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
  (U.S., Canada, Mexico)
• Europe
  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
  (Japan, China, India, Rest of Asia-Pacific)
• LAMEA
  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.